Navigation Links
New Treatments Help Fight Liver, Colon Cancer
Date:4/14/2008

Another therapy shows promise against pancreatic tumors, scientists say

MONDAY, April 14 (HealthDay News) -- A new drug duo might help prevent colorectal cancer, and the powerful new cancer drug Sutent may slow the progression of liver cancer.

So conclude two studies presented Monday at the American Association for Cancer Research annual meeting in San Diego.

In the first report, researchers found that a two-drug regimen made up of low doses of difluoromethylornithine (DFMO) plus sulindac, a non-steroidal anti-inflammatory drug (NSAID), cut the risk of colorectal adenomas by up to 95 percent. Colorectal adenomas are an early sign of colon cancer.

"We really think we are on track to develop a medical means to prevent colon cancer," lead researcher Dr. Frank L. Meyskens, a professor of medicine at the University of California, Irving, told reporters during a Monday afternoon teleconference.

Meyskens believes the drug combo could be used for people at high risk for colon cancer to prevent the disease from developing. It could also be used by those who have already had colon cancer, to help prevent its return, he said.

In the phase III trial, researchers studied 375 people with a history of colorectal polyps. They randomly assigned patients to a combination of DMFO and sulindac or placebo. Patients were followed for three years.

Patients taking the combination of drugs saw a 70 percent reduction in the risk of a new adenoma compared with patients receiving placebo.

For people who had advanced adenomas, the risk of developing new adenomas was reduced by 92 percent among those on the drug combination, Meyskens said.

Moreover, patients taking the drug combination who had had large adenomas saw a 90 percent reduction in their risk of developing new adenomas compared with patients taking placebo.

"The real home run was that we had a 95 percent decrease in new
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients
2. Study Points to New Treatments for Polycystic Kidney Disease
3. Twin findings raise hopes of improved anemia treatments
4. Developing cancer treatments directed at critical developmental pathway
5. Two Liver Cancer Treatments Better Than One
6. Microwave treatments for enlarged prostate cause blood pressure surges
7. ELLE Eco-Salon & Spa Rolls Thru Southern California Offering Styling, Mini- Makeovers and Beauty Treatments
8. Identification of dopamine mother cells could lead to future Parkinsons treatments
9. Enzyme complex could be key to new cancer treatments
10. Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL.org
11. Many Women Unclear About Breast Cancer Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Treatments Help Fight Liver, Colon Cancer
New Treatments Help Fight Liver, Colon Cancer
Breaking Medicine Technology:AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Pharmacy Technician Employment Increasing Up to 32% By 2016 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Pennsylvania Department of Health Launches Spanish Language Smoking Cessation Resource Web Site 47984 1Pennsylvania Department of Health Launches Spanish Language Smoking Cessation Resource Web Site 47984 2Illness and Medical Bills Linked to Nearly Two Thirds of All Bankruptcies 47982 1Illness and Medical Bills Linked to Nearly Two Thirds of All Bankruptcies 47982 2Illness and Medical Bills Linked to Nearly Two Thirds of All Bankruptcies 47982 3Illness and Medical Bills Linked to Nearly Two Thirds of All Bankruptcies 47982 4Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 1Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 2Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 3